Gynecological Cancers: Surgical Treatment and Novel Radiotherapy
Deadline for manuscript submissions: 27 March 2024 | Viewed by 1887
Interests: obstetrics and gynecology; endoscopy; cancer; laparoscopy; fertility preservation; medical therapies; genital prolapse; urinary incontinence; endometriosis; oncological gynecology
Special Issues, Collections and Topics in MDPI journals
Recent decades have witnessed significant advancements in surgical techniques for the treatment of gynecological cancers, resulting in shorter hospital stays, less blood loss, and lower morbidity levels due to the minimally invasive approach. It is now known that the histological categories of some gynecological tumors do not accurately differentiate the clinical course and response to therapy. Currently, a molecular profile study is being carried out to improve the risk stratification and targeted therapy for endometrial cancer.
Radiotherapy has an important place in the management of gynecological tumors, either as an upfront treatment or as an adjuvant in patients treated with surgery and harboring risk factors for locoregional relapse (e.g., endometrial cancer, early-stage cervical cancer, etc.).
Surgery is the mainstay of the treatment of endometrial cancer. The major evolution in surgical strategy has occurred in lymph node staging. The standard surgical staging includes pelvic and paraaortic lymph node dissection to the level of the left renal vein. Sentinel lymph node dissection has been validated as a less morbid alternative to systematic lymphadenectomy, indicated in patients with low and intermediate risk of lymph node involvement.
In particular, in ovarian cancer treatment, testing for the BRCA and HRD status is expected to further improve the prognosis by combining molecularly targeted agents with different mechanisms of action.
This Special Issue aims to collect original research studies and review articles that add to the current knowledge and showcase the potential future approaches of novel agents for gynecologic cancers.
Dr. Gaspare Cucinella
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- gynecological cancers
- uterine cancer
- cervical cancer
- vulvar cancer
- fertility preservation
- sentinel lymph node evaluation
- fertility-sparing treatment
- novel treatment strategies